Study of Bitopertin in Participants With EPP or XLP (APOLLO)
Trial details
- Registry ID
- NCT06910358
- Drugs studied
- DISC-1459
TrialRedline tracks 6 clinical trials sponsored by Disc Medicine, Inc: 1 Phase 3, 1 Phase 2 / 3, 3 Phase 2, 1 Phase 1 / 2.
Company identity checked against sources
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Study of Bitopertin in Participants With EPP or XLP (APOLLO)NCT06910358 | DISC-1459 | Completed | 2026-09-08Actual |
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLPNCT05883748 | DISC-1459 | Enrolling by invitation | 2028-06Estimated |
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Study of DISC-0974-201 in Participants With IBD and AnemiaNCT07368972 | DISC-0974 | Recruiting | 2026-10Estimated |
| A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)NCT06985147 | DISC-3405 | Active not recruiting | 2027-07Estimated |
| Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPPNCT05308472 | DISC-1459 | Completed | 2024-02-20Actual |
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and AnemiaNCT05320198 | DISC-0974 | Recruiting | 2027-05Estimated |
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2026-02-13Day | DISC-1459Disc Medicine, Inc · IRON | FDA complete response letterComplete response letter | Not specified | Open original sourceRead source excerpt{"application_number": ["NDA 220707"], "letter_date": "02/13/2026", "letter_type": "COMPLETE RESPONSE", "company_name": "Disc Medicine, Inc.", "file_name": "CRL_NDA220707_20260213.pdf"} First seen: 26 Sep 2026 · Evidence last checked: 26 Sep 2026 |
Names as written in the registry records.
NCT06985147 · Disc Medicine, Inc
Before: Feb 2027. After: Jul 2027.
NCT06910358 · Disc Medicine, Inc
Before: Estimated. After: Actual.
Before: Sep 2026. After: 8 Sep 2026.
Before: Active not recruiting. After: Completed.
NCT06985147 · Disc Medicine, Inc
Before: Recruiting. After: Active not recruiting.
NCT06910358 · Disc Medicine, Inc
Before: Estimated. After: Actual.
Before: 150 participants (planned). After: 183 participants (actual).
Before: Oct 2026. After: Sep 2026.
Before: Recruiting. After: Active not recruiting.
NCT07368972 · Disc Medicine, Inc
Before: Not yet recruiting. After: Recruiting.
Before: 200 participants (planned). After: 230 participants (planned).
NCT06985147 · Disc Medicine, Inc
Before: 20 participants (planned). After: 60 participants (planned).